It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 1993.
1993 | Hyderabad, Telangana, India | Struck OffStanmax Pharma Pvt Ltd, a struck off private limited company, was established on 25 June 1993 in Hyderabad, Telangana, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24235TG1993PTC015918. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.30 M.
Its leadership includes Ghanukota Rupa (Director), Dasari Sridhar (Director), Nyapathy Raghunandan (Director). It holds no open charges and ₹9.29 M settled loans. Its latest AGM occurred on 27 September 2014, with the balance sheet filed on 31 March 2014. It is based at 2-24-86/3/1,Laxmi Narayana Colony,Ida, Uppal, Hyderabad, Telangana, 500039.
U24235TG1993PTC015918
015918
25 June 1993
₹1.50 M
₹1.30 M
Roc Hyderabad
Unlisted
Struck Off
Explore comprehensive insights into Stanmax Pharma Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ghanukota Rupa | Director | 04 Apr 2007 | Current |
| Dasari Sridhar | Director | 04 Apr 2007 | Current |
| Nyapathy Raghunandan | Director | 04 Apr 2007 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Stanmax Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Stanmax Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹9,293,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Aug 2002 | A.P. State Financial Corporation | ₹9.29 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Stanmax Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Stanmax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stanmax Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Stanmax Pharma Pvt Ltd last Annual general meeting of members was held on 27 Sep 2014 as per latest MCA records. was recorded as a recent event.
Stanmax Pharma Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Hyderabad. was recorded as a recent event.
The activity Ghanukota Rupa was appointed as a Director was appointed as a Director on 04 Apr 2007 & has been associated with this company since 18 years 7 months . was completed.
Progress on Dasari Sridhar was appointed as a Director was appointed as a Director on 04 Apr 2007 & has been associated with this company since 18 years 7 months . was documented.
The activity Nyapathy Raghunandan was appointed as a Director was appointed as a Director on 04 Apr 2007 & has been associated with this company since 18 years 7 months . was completed.
A charge registered on 13 Aug 2002 via Charge ID 90134582 with A.P. State Financial Corporation was fully satisfied on 04 Jul 2005. was recorded as a recent event.
The CIN of Stanmax Pharma Pvt Ltd is U24235TG1993PTC015918.
Stanmax Pharma Pvt Ltd is headquartered at 2-24-86/3/1,Laxmi Narayana Colony,Ida, Uppal, Hyderabad, Telangana, 500039.
Stanmax Pharma Pvt Ltd was incorporated on 25 June 1993.
The current directors of Stanmax Pharma Pvt Ltd are
The primary industry of Stanmax Pharma Pvt Ltd is Chemicals.
Stanmax Pharma Pvt Ltd is unlisted.
The authorized capital of Stanmax Pharma Pvt Ltd is ₹1.50 M, and the paid-up capital is ₹1.30 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX